Literature DB >> 18488139

Multiple phospholipase activation by OX(1) orexin/hypocretin receptors.

L Johansson1, M E Ekholm, J P Kukkonen.   

Abstract

We investigated coupling of OX(1) receptors to phospholipase activation and diacylglycerol generation in Chinese hamster ovary (CHO) cells using both biochemical and fluorescence "real-time" methods. The results indicate that at lowest orexin-A concentrations (highest potency), diacylglycerol generated results from phospholipase D activity. At 10-100-fold higher orexin-A concentrations, phospholipase C is activated, likely hydrolyzing phosphatidylinositol (PI) or phosphatidylinositol monophosphate (PIP) but not phosphatidylinositol bisphosphate (PIP(2)). At further 7-fold higher orexin-A concentrations, PIP(2) is hydrolyzed, releasing both diacylglycerol and inositol-1,4,5-trisphosphate. Thus, OX(1) orexin receptors connect to multiple phospholipase activities, apparently composed of at least one phospholipase D and two different phospholipase C activities. At low agonist concentrations, diacylglycerol and phosphatidic acid are the preferred products, and interestingly, it seems that even the primarily activated phospholipase C mainly works to increase diacylglycerol and not inositol-1,4,5-trisphosphate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18488139     DOI: 10.1007/s00018-008-8206-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  12 in total

1.  Orexin/hypocretin receptor signalling: a functional perspective.

Authors:  C S Leonard; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

2.  Orexin A-induced extracellular calcium influx in prefrontal cortex neurons involves L-type calcium channels.

Authors:  J X Xia; S Y Fan; J Yan; F Chen; Y Li; Z P Yu; Z A Hu
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

Review 3.  Role of orexin receptors in obesity: from cellular to behavioral evidence.

Authors:  C E Perez-Leighton; T A Butterick-Peterson; C J Billington; C M Kotz
Journal:  Int J Obes (Lond)       Date:  2012-03-06       Impact factor: 5.095

4.  OX1 orexin/hypocretin receptor activation of phospholipase D.

Authors:  M H Jäntti; J Putula; P Somerharju; M A Frohman; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  Orexin/hypocretin receptor signalling cascades.

Authors:  J P Kukkonen; C S Leonard
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

6.  Orexin receptors in GtoPdb v.2021.3.

Authors:  Paul Coleman; Luis de Lecea; Anthony Gotter; Jim Hagan; Daniel Hoyer; Thomas Kilduff; Jyrki P Kukkonen; Rod Porter; John Renger; Jerome M Siegel; Gregor Sutcliffe; Neil Upton; Christopher J Winrow
Journal:  IUPHAR BPS Guide Pharm CITE       Date:  2021-09-02

7.  Arachidonic acid release mediated by OX1 orexin receptors.

Authors:  Pauli M Turunen; Marie E Ekholm; Pentti Somerharju; Jyrki P Kukkonen
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

Review 8.  Brain orexin promotes obesity resistance.

Authors:  Catherine Kotz; Joshua Nixon; Tammy Butterick; Claudio Perez-Leighton; Jennifer Teske; Charles Billington
Journal:  Ann N Y Acad Sci       Date:  2012-07-17       Impact factor: 5.691

9.  Choline-Sigma-1R as an Additional Mechanism for Potentiation of Orexin by Cocaine.

Authors:  Jeffrey L Barr; Pingwei Zhao; G Cristina Brailoiu; Eugen Brailoiu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

10.  Orexin A inhibits propofol-induced neurite retraction by a phospholipase D/protein kinase Cε-dependent mechanism in neurons.

Authors:  Karin Björnström; Dean Turina; Tobias Strid; Tommy Sundqvist; Christina Eintrei
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.